DK0586589T3 - Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande - Google Patents

Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande

Info

Publication number
DK0586589T3
DK0586589T3 DK92913606.7T DK92913606T DK0586589T3 DK 0586589 T3 DK0586589 T3 DK 0586589T3 DK 92913606 T DK92913606 T DK 92913606T DK 0586589 T3 DK0586589 T3 DK 0586589T3
Authority
DK
Denmark
Prior art keywords
amylin
anorexia
treatment
pct
analogue
Prior art date
Application number
DK92913606.7T
Other languages
English (en)
Inventor
Timothy J Rink
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0586589T3 publication Critical patent/DK0586589T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92913606.7T 1991-05-24 1992-05-23 Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande DK0586589T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70499591A 1991-05-24 1991-05-24
US86250092A 1992-04-03 1992-04-03

Publications (1)

Publication Number Publication Date
DK0586589T3 true DK0586589T3 (da) 1997-09-22

Family

ID=27107425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92913606.7T DK0586589T3 (da) 1991-05-24 1992-05-23 Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande

Country Status (11)

Country Link
US (1) US5656590A (da)
EP (1) EP0586589B1 (da)
JP (1) JPH06510754A (da)
AT (1) ATE157010T1 (da)
AU (1) AU669110B2 (da)
CA (1) CA2109794A1 (da)
DE (1) DE69221725T2 (da)
DK (1) DK0586589T3 (da)
ES (1) ES2108122T3 (da)
SG (1) SG49239A1 (da)
WO (1) WO1992020367A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE69426304T2 (de) 1993-09-07 2001-03-15 Amylin Pharmaceuticals Inc Methoden zur regulation der den magen und darm betreffenden motilitaet
AUPM678294A0 (en) * 1994-07-13 1994-08-04 Gropep Pty Ltd Use of insulin-like growth factor in combination with insulin
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US6621131B2 (en) * 2001-11-01 2003-09-16 Intel Corporation Semiconductor transistor having a stressed channel
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
NZ541365A (en) * 2002-12-27 2009-09-25 Diobex Inc Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20070275877A1 (en) * 2003-08-29 2007-11-29 Amylin Pharmaceuticals, Inc. Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
EP2010208A1 (en) * 2006-03-31 2009-01-07 Amylin Pharmaceuticals, Inc. Amylin and amylin agonists for treating psychiatric diseases and disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5049547A (en) * 1988-02-11 1991-09-17 University Patents, Inc. Composition for stimulating integumental melanocytes
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment
CA2020786A1 (en) * 1989-07-10 1991-01-11 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders
US5016643A (en) * 1990-05-02 1991-05-21 Board Of Regents, The University Of Texas System Vascular entoptoscope
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
EP0586592B1 (en) * 1991-05-24 2000-11-29 Amylin Pharmaceuticals, Inc. Insulin and amylin containing composition for the treatment of insulin deficient mammals

Also Published As

Publication number Publication date
DE69221725D1 (de) 1997-09-25
JPH06510754A (ja) 1994-12-01
WO1992020367A1 (en) 1992-11-26
EP0586589B1 (en) 1997-08-20
CA2109794A1 (en) 1992-11-26
ATE157010T1 (de) 1997-09-15
US5656590A (en) 1997-08-12
DE69221725T2 (de) 1997-12-18
AU669110B2 (en) 1996-05-30
EP0586589A1 (en) 1994-03-16
SG49239A1 (en) 1998-05-18
ES2108122T3 (es) 1997-12-16
AU2011592A (en) 1992-12-30

Similar Documents

Publication Publication Date Title
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
DK0656774T3 (da) Kosmetiske og dermatologiske lysbeskyttelsesformuleringer med et indhold af thioler og/eller thiolderivater
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DK0693285T3 (da) Farmaceutiske præparater, der indeholder et bisphosphonat og et antiresorberende middel til inhibering af knogletab
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
DK0586589T3 (da) Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
ES2131528T3 (es) Nuevos polipeptidos y su uso.
DK0648120T3 (da) Anvendelse af phosphonater til behandling af osteoporose
HK83293A (en) Composition of pregnanolole comprising a stable oil-in-water emulsion
ATE108652T1 (de) Bis(alkyl-substituierte-4-hydroxyphenylthio)alk n-analoga als inhibitoren der kataraktentstehung.
NO971903D0 (no) Krystallisering av levobupivacain og analoger derav
FI951511A (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
DK0607278T3 (da) Fremgangsmåde til forstærkning af tarmabsorption
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
IT1249047B (it) Composizione farmaceutica per il trattamento della cataratta
TW261532B (da)
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
ATE167690T1 (de) Polyetheramidoamine hydrogele als heparinersatz
DK0869785T3 (da) 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
FI950696A (fi) Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.